Dolgin, Elie
Para>Elie Dolgin is a science writer in Somerville,
United States
2025 Rank: 10865
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Developmental Biology
Rank in SubField 1: 219 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10865 | 12572 |
| Total Cites | 431 | 431 |
| H-index | 10 | 10 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 236 | 236 |
| Total Cites to Single Authored Papers | 425 | 425 |
| Number of Single+First Authored Papers | 237 | 237 |
| Total Cites to Single+First Authored Papers | 425 | 425 |
| Number of Single+First+Last Authored Papers | 239 | 239 |
| Total Cites to Single+First+Last Authored Papers | 429 | 429 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 422 | 422 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.02 |
| Self-Citation Percentage |
0.00%
|
|
Dolgin, Elie
Science journalist,
United States
2024 Rank: 5560
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 17 out of 62673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 5560 | 6427 |
| Total Cites | 587 | 587 |
| H-index | 11 | 11 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 160 | 160 |
| Total Cites to Single Authored Papers | 585 | 585 |
| Number of Single+First Authored Papers | 160 | 160 |
| Total Cites to Single+First Authored Papers | 585 | 585 |
| Number of Single+First+Last Authored Papers | 161 | 161 |
| Total Cites to Single+First+Last Authored Papers | 587 | 587 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 573 | 573 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.02 |
| Self-Citation Percentage |
0.00%
|
|
Dolgin, Elie
MA,
United States
2023 Rank: 3847
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Developmental Biology
Rank in SubField 1: 16 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3847 | 4524 |
| Total Cites | 638 | 638 |
| H-index | 13 | 13 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 149 | 149 |
| Total Cites to Single Authored Papers | 632 | 632 |
| Number of Single+First Authored Papers | 149 | 149 |
| Total Cites to Single+First Authored Papers | 632 | 632 |
| Number of Single+First+Last Authored Papers | 150 | 150 |
| Total Cites to Single+First+Last Authored Papers | 638 | 638 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 624 | 624 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.02 |
| Self-Citation Percentage |
0.00%
|
|
Dolgin, Elie
Nature Medicine,
United States
2022 Rank: 21341
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Developmental Biology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 695 out of 127685 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21341 | 25153 |
| Total Cites | 288 | 288 |
| H-index | 8 | 8 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 81 | 81 |
| Total Cites to Single Authored Papers | 279 | 279 |
| Number of Single+First Authored Papers | 81 | 81 |
| Total Cites to Single+First Authored Papers | 279 | 279 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 287 | 287 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 286 | 286 |
| Ratio of Total Citations to Distinct Citing Papers | 1.01 | 1.01 |
| Self-Citation Percentage |
0.00%
|
|
Dolgin, Elie
Nature Medicine,
United States
2021 Rank: 46145
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nursing
SubField 2:
Developmental Biology
Rank in SubField 1: 114 out of 90621 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46145 | 54553 |
| Total Cites | 303 | 303 |
| H-index | 8 | 8 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 75 | 75 |
| Total Cites to Single Authored Papers | 265 | 265 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 265 | 265 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 301 | 301 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 302 | 302 |
| Ratio of Total Citations to Distinct Citing Papers | 1.00 | 1.00 |
| Self-Citation Percentage |
0.00%
|
|
Dolgin, Elie
None,
United States
2020 Rank: 51846
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nursing
SubField 2:
Developmental Biology
Rank in SubField 1: 92 out of 35893 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51846 | 61909 |
| Total Cites | 214 | 214 |
| H-index | 7 | 7 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 61 | 61 |
| Total Cites to Single Authored Papers | 177 | 177 |
| Number of Single+First Authored Papers | 61 | 61 |
| Total Cites to Single+First Authored Papers | 177 | 177 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 212 | 212 |
| Composite Score | 3 | 2 |
| Number of Distinct Citing Papers | 214 | 214 |
| Ratio of Total Citations to Distinct Citing Papers | 1.00 | 1.00 |
| Self-Citation Percentage |
0.00%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.